*ST中潤(000506.SZ):控股股東寧波冉盛籌劃公司控制權轉讓事宜 明起停牌
格隆匯10月7日丨*ST中潤(000506.SZ)公佈,公司於2024年9月30日收到控股股東寧波冉盛盛遠投資管理合夥企業(有限合夥)(以下簡稱"寧波冉盛")的通知,寧波冉盛籌劃有關公司控制權轉讓事宜,本次籌劃擬轉讓的股份約佔公司總股本20%左右,交易對手方為礦業行業的大型企業,本次交易尚需交易對手方履行審批程序。該事項進入洽談中,目前尚存在重大不確定性。
經公司向深圳證券交易所申請,公司股票(證券代碼:000506,證券簡稱:*ST中潤)自2024年10月8日(星期二)開市起停牌,停牌時間預計不超過2個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.